Standards Comparison

    FDA 21 CFR Part 11

    Mandatory
    1997

    FDA regulation for electronic records/signatures equivalence to paper

    VS

    EN 1090

    Mandatory
    2009

    EU standard for steel and aluminium structures execution

    Quick Verdict

    FDA 21 CFR Part 11 ensures electronic records' trustworthiness for US life sciences, while EN 1090 mandates CE-marked structural steel/aluminium execution for EU construction. Companies adopt Part 11 for data integrity compliance; EN 1090 for mandatory market access and liability protection.

    Electronic Records

    FDA 21 CFR Part 11

    21 CFR Part 11 Electronic Records; Electronic Signatures

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Establishes equivalency criteria for electronic records/signatures to paper
    • Mandates secure, time-stamped audit trails for changes
    • Requires unique, linked electronic signatures with non-repudiation
    • Differentiates controls for closed versus open systems
    • Enforces risk-based validation and access checks
    Structural Metalwork

    EN 1090

    EN 1090 Execution of steel and aluminium structures

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    6-12 months

    Key Features

    • Risk-based Execution Classes (EXC1-EXC4)
    • Factory Production Control (FPC) certification
    • Responsible Welding Coordinator (rWC) requirement
    • CE marking and Declaration of Performance
    • Material and weld full traceability

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    FDA 21 CFR Part 11 Details

    What It Is

    FDA 21 CFR Part 11 is a U.S. regulation defining criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It scopes FDA-regulated records under predicate rules, using a control-based approach with risk-based enforcement discretion per 2003 guidance.

    Key Components

    • **Subpart BClosed (§11.10)/open (§11.30) system controls including validation, audit trails, access/authority/device checks.
    • **Subpart CSignature requirements (§§11.50-11.300) for manifestation, linking, uniqueness, multi-component controls.
    • Enduring principles: data integrity, non-repudiation, ALCOA+. Compliance via inspection, no certification.

    Why Organizations Use It

    • Mandatory for electronic reliance to avoid enforcement.
    • Ensures integrity for quality/safety decisions.
    • Drives efficiency, digital transformation.
    • Builds FDA trust, reduces inspection risks.

    Implementation Overview

    Risk-based: scope records, classify systems, CSV (URS, IQ/OQ/PQ), SOPs/training. Targets pharma/biotech/devices; multi-phase for any size, ongoing governance.

    EN 1090 Details

    What It Is

    EN 1090 is the harmonized European standard family (EN 1090-1 for conformity assessment, EN 1090-2/3 for technical execution of steel/aluminium structures). It operationalizes the EU Construction Products Regulation (CPR), mandating CE marking for load-bearing components in the EEA. Its risk-based methodology employs Execution Classes (EXC 1-4) to scale controls by failure consequences, service, and production categories.

    Key Components

    • **Factory Production Control (FPC)Documented, NB-certified system for traceability, inspection, and processes.
    • **Welding governanceResponsible Welding Coordinator (rWC), WPS/PQR/WPQR per ISO 3834.
    • **Technical rulesMaterials, tolerances, NDT, corrosion protection.
    • **CertificationInitial audits, ITT/ITC (manufacturer-led), ongoing surveillance.

    Why Organizations Use It

    • Mandatory for legal market access and CE marking.
    • Mitigates liability via traceability and quality controls.
    • Enables tenders, builds stakeholder trust.
    • Drives operational maturity, reduces rework.

    Implementation Overview

    Phased roadmap: gap analysis, FPC design, personnel training, NB engagement. Targets steel/aluminium fabricators in EU/EEA; suits all sizes with welding focus. Requires NB certification and surveillance. (178 words)

    Key Differences

    Scope

    FDA 21 CFR Part 11
    Electronic records/signatures trustworthiness
    EN 1090
    Steel/aluminium structural execution/conformity

    Industry

    FDA 21 CFR Part 11
    Life sciences, pharma, medical devices (US)
    EN 1090
    Construction, steel/aluminium fabrication (EU/EEA)

    Nature

    FDA 21 CFR Part 11
    US FDA regulation with enforcement discretion
    EN 1090
    Mandatory EU harmonized standard for CE marking

    Testing

    FDA 21 CFR Part 11
    Risk-based system validation, audit trails
    EN 1090
    FPC certification, ITT/ITC, NB surveillance audits

    Penalties

    FDA 21 CFR Part 11
    Warning letters, product holds, enforcement
    EN 1090
    Certificate suspension, market exclusion, liability

    Frequently Asked Questions

    Common questions about FDA 21 CFR Part 11 and EN 1090

    FDA 21 CFR Part 11 FAQ

    EN 1090 FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages